Resmed (RMD) Change in Cash (2009 - 2026)

Resmed (RMD) has 18 years of Change in Cash data on file, last reported at $243.4 million in Q1 2026.

• Quarterly Change in Cash fell 40.73% year-over-year to $243.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $727.8 million (up 4.75% YoY) and the FY2025 annual result came in at $971.1 million, up 9174.97% from the prior year.
• Change in Cash advanced to $243.4 million in Q1 2026, from $33.2 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $410.8 million in Q1 2025 to a low of -$66.5 million in Q3 2022.
• A 5-year average of $86.2 million and a median of $33.2 million in 2025 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash tumbled 446.98% — and 2025, when it jumped 61261.2%.
• Tracing RMD's Change in Cash over 5 years: stood at $46.0 million in 2022, then sank by 97.51% to $1.1 million in 2023, then jumped by 8233.3% to $95.6 million in 2024, then sank by 65.24% to $33.2 million in 2025, then surged by 632.8% to $243.4 million in 2026.
• The last three Change in Cash figures came in at $243.4 million (Q1 2026), $33.2 million (Q4 2025), and $174.4 million (Q3 2025), per Business Quant data.